Skye Bioscience, Inc.SKYENASDAQ
LOADING
|||
Operating Income Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year operating income growth rate
Latest
13.08%
↑ 138% above average
Average (9y)
-34.04%
Historical baseline
Range
High:13.69%
Low:-133.34%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| 2024 | 13.08% |
| 2023 | -89.69% |
| 2022 | -133.34% |
| 2021 | -24.78% |
| 2020 | 5.19% |
| 2019 | -41.34% |
| 2018 | -21.61% |
| 2017 | 13.69% |
| 2016 | -3.56% |
| 2015 | -58.02% |